Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
13.90
+0.87 (6.68%)
At close: Mar 31, 2026, 4:00 PM EDT
13.95
+0.05 (0.36%)
Pre-market: Apr 1, 2026, 4:33 AM EDT
Janux Therapeutics Stock Forecast
Stock Price Forecast
The 10 analysts that cover Janux Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $53.6, which forecasts a 285.61% increase in the stock price over the next year. The lowest target is $12 and the highest is $100.
Price Target: $53.6 (+285.61%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Feb 27, 2026.
Analyst Ratings
The average analyst rating for Janux Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 6 | 5 | 5 | 5 |
| Buy | 5 | 5 | 4 | 4 | 4 | 4 |
| Hold | 1 | 2 | 2 | 3 | 3 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 12 | 12 | 12 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $150 → $100 | Buy | Maintains | $150 → $100 | +619.42% | Feb 27, 2026 |
| Guggenheim | Guggenheim | Strong Buy Maintains $72 → $68 | Strong Buy | Maintains | $72 → $68 | +389.21% | Feb 27, 2026 |
| Clear Street | Clear Street | Strong Buy → Hold Downgrades $32 → $12 | Strong Buy → Hold | Downgrades | $32 → $12 | -13.67% | Jan 20, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $42 → $30 | Buy | Maintains | $42 → $30 | +115.83% | Jan 16, 2026 |
| Barclays | Barclays | Buy Maintains $48 → $29 | Buy | Maintains | $48 → $29 | +108.63% | Dec 17, 2025 |
Financial Forecast
Revenue This Year
4.92M
from 10.00M
Decreased by -50.82%
Revenue Next Year
4.81M
from 4.92M
Decreased by -2.11%
EPS This Year
-2.75
from -1.83
EPS Next Year
-3.33
from -2.75
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 52.5M | 35.3M | |||
| Avg | 4.9M | 4.8M | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 425.0% | 618.1% | |||
| Avg | -50.8% | -2.1% | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -1.91 | -1.73 | |||
| Avg | -2.75 | -3.33 | |||
| Low | -3.58 | -5.84 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.